EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Micronutrient Treatment for Irritability in Adolescents: 8-Week Double-Blinded Randomized Placebo-Controlled Trial (BEAM)

Julia J Rucklidge, Angela H Sherwin, Roger T Mulder, Leona Manna, Joseph M Boden

Journal of the American Academy of Child & Adolescent Psychiatry · 2026-02

DOI: 10.1016/j.jaac.2026.01.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Child & Adolescent Psychiatry, 2026-02. Verfasst von Julia J Rucklidge und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Canterbury, Christchurch, New Zealand. Electronic address: julia.rucklidge@canterbury.ac.nz. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Irritability is a transdiagnostic dimension characterized by affective and behavioral components. The Balancing Emotions of Adolescents with Micronutrients (BEAM) study investigated broad-spectrum micronutrient (vitamins and minerals) efficacy and safety for adolescents with moderate-to-severe irritability symptoms. METHOD: A total of 132 unmedicated adolescents (12-17 years of age) were randomized to micronutrients (n = 67) or active placebo (n = 65) for 8 weeks and monitored remotely with weekly parent/adolescent questionnaires and monthly online meetings with a registered psychologist. Primary outcome measures were the Clinical Global Impression-Improvement (CGI-I), Emotion Dysregulation Inventory (EDI)-Reactivity subscale, and Clinician Affective Reactivity Index (CL-ARI-Total). RESULTS: Both groups were well matched at baseline. Generalized linear mixed-effect regression models showed significant main effects of treatment on the CGI-I (p = .012), EDI (p = .043), but not CL-ARI-Total (p = .276), although the rate of change over time did not significantly differ between treatment groups. Post hoc analyses showed disruptive mood dysregulation disorder (DMDD) and socio-economic status (SES) modified treatment response; those with DMDD and from lower SES families were more likely to respond to micronutrients. For the entire sample, baseline to end-of-RCT between-group effect sizes (ES) were small-to-medium (0.30-0.36) whereas for those with DMDD (n=30), ES were very large (1.06-1.44); 64.3% of DMDD participants were responders on micronutrients compared with 12.5% on placebo (p = .003, relative risk [RR] = 4.053; NNT = 1.9). Secondary outcomes highlighted significant benefits of micronutrients over placebo on CGI-Severity, parent-reported conduct symptoms and prosocial behavior, and adolescent-reported suicidal ideation. Micronutrients also led to faster improvement in clinician-rated irritability, parent-rated dysphoria, and adolescent-rated quality of life, stress, and prosocial behaviors. Only one side effect differed significantly between groups: temporary diarrhea was more common on micronutrients (20.9%) than on placebo (6.2%; p = 0.02, RR = 3.40). A minority of participants (

Schlagwörter

Stichwörter der Autor:innen

irritabilitymicronutrientsmineralsmultinutrientsyouth

Autor:innen und Institutionen

  • University of Canterbury, Christchurch, New Zealand. Electronic address: julia.rucklidge@canterbury.ac.nz.
  • University of Canterbury, Christchurch, New Zealand.
  • University of Otago, Christchurch, New Zealand.

Förderung

  • Health Research Council of New Zealand

Zitieren

APA

Rucklidge, J. J., Sherwin, A. H., Mulder, R. T., Manna, L., & Boden, J. M. (2026). Efficacy and Safety of Micronutrient Treatment for Irritability in Adolescents: 8-Week Double-Blinded Randomized Placebo-Controlled Trial (BEAM). Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2026.01.013

Vancouver

Rucklidge JJ, Sherwin AH, Mulder RT, Manna L, Boden JM. Efficacy and Safety of Micronutrient Treatment for Irritability in Adolescents: 8-Week Double-Blinded Randomized Placebo-Controlled Trial (BEAM). Journal of the American Academy of Child & Adolescent Psychiatry. 2026. doi:10.1016/j.jaac.2026.01.013

BibTeX
@article{Rucklidge2026,
  author = {Rucklidge, Julia J and Sherwin, Angela H and Mulder, Roger T and Manna, Leona and Boden, Joseph M},
  title = {Efficacy and Safety of Micronutrient Treatment for Irritability in Adolescents: 8-Week Double-Blinded Randomized Placebo-Controlled Trial (BEAM)},
  journal = {Journal of the American Academy of Child & Adolescent Psychiatry},
  year = {2026},
  doi = {10.1016/j.jaac.2026.01.013}
}
Kostenlos starten →